NCT07183280Recruiting
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
The Construction and Maintenance of A Real World Study Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To establish and maintain a reliable multicenter real-world database for pancreatic SPN, providing high-quality data and evidence-based support for clinical/translational research.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 8 Sept 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 30 Dec 2040
- Lead sponsor
- Fudan University
- Diseases
- Pancreatic cancer, Childhood cancers
- NCT number
- NCT07183280
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Sept 2025 to the primary completion date, 30 Dec 2040
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-neoplastic pancreatic lesions;
- Non-pancreatic primary tumors;
- Non-compliance with follow-up;
Who the study is looking for
- No restrictions on age, gender, or performance status;
- Pathologically/cytologically confirmed SPN;
- Compliance with follow-up requirements;
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
Related publications
- Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.Eur J Cancer · 2026 · PMID 42759262
This page is information, not medical advice. Discuss any trial with your doctor.